1 authorised product containing REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H1N1) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Fluenz nasal spray suspension Influenza vaccine (live, nasal) EU/1/24/1816/001-002 |
REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) B/<OFFICIAL STRAIN> LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H3N2) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H1N1) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML | AstraZeneca AB | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.